Introduction to the PEPAIR OPEP Device

Zydus Lifesciences recently launched the PEPAIR OPEP device to support patients with chronic lung conditions. This handheld tool assists individuals suffering from COPD, asthma, and bronchiectasis. Furthermore, it represents India's first affordable solution for airway clearance at just Rs. 990. Because chronic mucous hypersecretion affects over 90 lakh Indian patients, this launch is a significant healthcare milestone. Consequently, Zydus aims to simplify pulmonary rehabilitation across the country.

Mechanism and Benefits of the PEPAIR OPEP Device

The device utilizes Oscillating Positive Expiratory Pressure therapy to clear airway congestion. When patients exhale through the translucent device, it generates specific pressure and vibrations. These oscillations effectively loosen stubborn mucous from the bronchial walls. Additionally, the patented three-resistance system allows for customized therapy based on patient needs. Therefore, users can achieve better breathing without the need for additional medication.

Addressing India's Growing Respiratory Burden

Respiratory diseases are rising sharply in India due to extreme air pollution and rapid urbanization. Specifically, delayed diagnosis of chronic lung conditions often leads to impaired mucociliary pathways. However, the PEPAIR OPEP device helps remove airway obstructions and reduces persistent coughing. Zydus developed this innovation in agreement with AeroDel Technology Innovations. Moreover, clinical guidance recommends OPEP therapy for effective everyday care.

Frequently Asked Questions

Q1: What is the primary function of the PEPAIR OPEP device?

The PEPAIR OPEP device creates pressure and vibrations during exhalation to loosen mucous and open airways. It functions as a drug-free tool to assist patients with COPD, asthma, and bronchiectasis in clearing their lungs.

Q2: Who can benefit from using this device?

It is specifically designed for individuals with chronic respiratory conditions who suffer from excessive mucous production. This includes patients with asthma or bronchiectasis seeking an affordable airway clearance solution.

Q3: How much does the PEPAIR device cost in India?

Zydus has launched the device at an affordable price of Rs. 990 per unit to ensure broader accessibility for Indian patients.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Zydus launches device for respiratory issues - ETHealthworld


2. AeroDel Technology Innovations. (2026). PEPAIR Product Specifications and Pulmonary Rehabilitation Solutions.


3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2024). Global Strategy for the Diagnosis, Management, and Prevention of COPD.